We are live on ! Find out more
FFO

Fortitude Family Office Portfolio holdings

AUM $516M
1-Year Est. Return 28.38%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+28.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$448M
AUM Growth
+$17.9M
Cap. Flow
+$16.8M
Cap. Flow %
3.76%
Top 10 Hldgs %
46.12%
Holding
2,122
New
203
Increased
1,029
Reduced
323
Closed
236

Top Sells

Rank Stock Value
1
KNX icon
Knight Transportation
KNX
+$10.6M
2
AAPL icon
Apple
AAPL
+$3.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$2.89M
4
CVX icon
Chevron
CVX
+$2.07M
5
JPM icon
JPMorgan Chase
JPM
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 5.6%
2 Financials 2.23%
3 Energy 2.13%
4 Consumer Staples 1.9%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAMA icon
1726
Mama's Creations
MAMA
$822M
$506 ﹤0.01%
33
-82
-71% -$1.25K
ALGS icon
1727
Aligos Therapeutics
ALGS
$47.8M
$505 ﹤0.01%
+68
New +$516
NKTR icon
1728
Nektar Therapeutics
NKTR
$2.53B
$504 ﹤0.01%
7
-14
-67% -$797
NNN icon
1729
NNN REIT
NNN
$8.8B
$504 ﹤0.01%
12
CDNA icon
1730
CareDx
CDNA
$2.44B
$503 ﹤0.01%
+29
New +$549
ERIE icon
1731
Erie Indemnity
ERIE
$13.2B
$503 ﹤0.01%
2
-1
-33% -$268
MARA icon
1732
Marathon Digital Holdings
MARA
$3.69B
$498 ﹤0.01%
61
-36
-37% -$326
AUR icon
1733
Aurora
AUR
$13.7B
$494 ﹤0.01%
120
UNCY icon
1734
Unicycive Therapeutics
UNCY
$138M
$494 ﹤0.01%
+75
New +$491
DAWN
1735
DELISTED
Day One Biopharmaceuticals
DAWN
$493 ﹤0.01%
+23
New +$324
BLMN icon
1736
Bloomin' Brands
BLMN
$944M
$491 ﹤0.01%
+91
New +$583
ZNTL icon
1737
Zentalis Pharmaceuticals
ZNTL
$297M
$489 ﹤0.01%
+209
New +$540
SG icon
1738
Sweetgreen
SG
$648M
$488 ﹤0.01%
+94
New +$571
YORW icon
1739
York Water
YORW
$518M
$487 ﹤0.01%
16
RGNX icon
1740
Regenxbio
RGNX
$688M
$486 ﹤0.01%
+58
New +$609
MGRX icon
1741
Mangoceuticals
MGRX
$10.2M
$484 ﹤0.01%
1,343
+965
+255% +$462
UMAC icon
1742
Unusual Machines
UMAC
$1.36B
$484 ﹤0.01%
+39
New +$594
IMMX icon
1743
Immix Biopharma
IMMX
$721M
$483 ﹤0.01%
+53
New +$389
ANNX icon
1744
Annexon
ANNX
$883M
$482 ﹤0.01%
+87
New +$490
NRIX icon
1745
Nurix Therapeutics
NRIX
$2.69B
$481 ﹤0.01%
+31
New +$514
SEPN
1746
Septerna Inc
SEPN
$1.75B
$481 ﹤0.01%
20
-51
-72% -$1.34K
CZR icon
1747
Caesars Entertainment
CZR
$6.13B
$476 ﹤0.01%
+18
New +$428
QDEL icon
1748
QuidelOrtho
QDEL
$938M
$476 ﹤0.01%
+29
New +$712
TTD icon
1749
Trade Desk
TTD
$6.29B
$476 ﹤0.01%
+21
New +$606
RLYB icon
1750
Rallybio
RLYB
$88.2M
$475 ﹤0.01%
+53
New +$362

Similar funds

Fortitude Family Office's Q1 2026 Portfolio in Review

As of Q1 2026, Fortitude Family Office held 2,122 positions worth $448M, up 4.2% from $430M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fortitude Family Office deployed $16.8M of net new capital in Q1 2026, opening 203 new positions and adding to 1,029 existing holdings. Its largest new stake was Avantis Total Equity Markets ETF: 710,489 shares worth $33.4M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 8.1% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Knight Transportation, an estimated $10.6M trimmed.

  • Fortitude Family Office's largest Q1 2026 buy was Avantis Total Equity Markets ETF: 710,489 shares worth $33.4M.
  • Fortitude Family Office added most to Vanguard 0-3 Month Treasury Bill ETF in Q1 2026, an estimated $4.05M increase.
  • Fortitude Family Office's biggest Q1 2026 reduction was Knight Transportation, cutting an estimated $10.6M.
  • Fortitude Family Office fully exited iShares MSCI Israel ETF in Q1 2026, selling an estimated $254K.
  • Fortitude Family Office's ten largest holdings make up 46% of its $448M portfolio in Q1 2026.
  • Fortitude Family Office opened 203 new positions and closed 236 in Q1 2026.
  • Fortitude Family Office's portfolio value rose 4.2% quarter-over-quarter to $448M.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.